Harrow, Inc. (HROW) stock
HROWNasdaqPharmaceutical PreparationsFiscal year ends December 31
$30.12+1.82 (+6.43%)
Close on Nov 13, 2026Market cap $1.13BP/E –Yield –
Harrow enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Harrow's enterprise value was $1.31B on Nov 11, 2026, against $1.72B a year earlier. Over the last 5 years it ranged from $202.55M to $2.19B, with a median of $846.93M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $1.31B | -34.0% |
| 2025 | Dec 31, 2025 | $1.98B | +51.6% |
| 2024 | Dec 31, 2024 | $1.31B | +160.9% |
| 2023 | Dec 29, 2023 | $501.27M | +18.7% |
| 2022 | Dec 30, 2022 | $422.38M | +79.1% |
| 2021 | Dec 31, 2021 | $235.90M | +29.4% |
| 2020 | Dec 31, 2020 | $182.23M | -11.0% |
| 2019 | Dec 31, 2019 | $204.82M | +51.4% |
| 2018 | Dec 31, 2018 | $135.27M | +206.8% |
| 2017 | Dec 29, 2017 | $44.09M | +11.5% |
| 2016 | Dec 30, 2016 | $39.53M | -34.7% |
| 2015 | Dec 31, 2015 | $60.54M | +2.6% |
| 2014 | Dec 31, 2014 | $58.99M | +343.1% |
| 2013 | Dec 31, 2013 | $13.31M | -75.8% |
| 2012 | Dec 31, 2012 | $55.04M | +260.6% |
| 2011 | Dec 30, 2011 | $15.26M | +725.0% |
| 2009 | Feb 27, 2009 | $1.85M | – |
See a number that looks wrong?